Acuity Spatial Genomics, Inc
Lei Zhu is a highly experienced scientist with expertise in molecular and cell biology, plant biology, and genetics. Currently serving as a Staff Scientist at Acuity Spatial Genomics, Inc., since June 2022, Lei Zhu focuses on R&D reagents, assays, and product development. Previously, Lei Zhu held the position of Senior Scientist at PacBio, contributing to significant advancements such as the development of PGx CYP2D6 sequencing and the SMRTbell enzyme cleanup kit v2. Notable achievements include first-author poster presentations at major genetics conferences. Additional experience includes roles at Elim Biopharmaceuticals and Centrillion Biosciences, where Lei Zhu led product development for genomic applications. A postdoctoral scholar at UC Berkeley, Lei Zhu specialized in the characterization of glycosyltransferases. Lei Zhu obtained a Ph.D. in Molecular and Cell Biology from the University of California, Riverside, and a Master's Degree in Genetics from Iowa State University.
Acuity Spatial Genomics, Inc
Acuity Spatial Genomics, Inc. provides a ground-breaking platform designed for simultaneous, genome-wide visualization of the 3D genome in single cells and opens new frontiers in spatial multiomic analyses for discovery. Based on patented technologies developed at Harvard University, the company’s OligoFISSEQ and OligoFISSEQ HD technologies empower researchers to visualize the genome organization and 3D chromatin architecture of individual cells, directly in situ, and in an accessible time-to-result and cost-effective approach. The Acuity technology platform enables the possibility to delve deeper and gain critical insight into transcription regulatory programs that drive cell type, state, function, and pathogenesis—and thus advance discovery in areas such as oncology, neuroscience, and disease research. The company has facilities in Massachusetts and California.